COVID-19 Outbreak Information –

15 documents found for "/search-result/".

Introduction to PolyPeptide Group

Introduction to PolyPeptide Group POLYPEPTIDE GROUP Business update & H1 2021 results 17 August 2021 2 Agenda 1 2 3 4 Introduction H1 Financial Results Priorities & Outlook Raymond De Vré, CEO Jan Fuhr Miller, CFO Raymond De Vré, CEO Q&A All 3 Disclaimer This presentation (the "Presentation") has ...

Read more

Microsoft Word - PPL IASB FS 2020 (FINAL).docx

Microsoft Word - PPL IASB FS 2020 (FINAL).docx POLYPEPTIDE LABORATORIES HOLDING B.V. Consolidated Financial Statements 2020 POLYPEPTIDE LABORATORIES HOLDING B.V., HOOFDDORP, THE NETHERLANDS CONTENTS Consolidated Income Statement 2 Consolidated Statement of Comprehensive Income 3 Consolidated Stateme...

Read more

Corporate News – PolyPeptide

Corporate News – PolyPeptide COVID-19 Outbreak Information – Click here for the latest updates Services GMP Compliance Pre-GMP development Production Quality Assurance Quality control Regulatory Support Generic peptides Commercial Manufacturing Commercial Products at PolyPeptide Late Stage Devel...

Read more

https://group.polypeptide.com/app/uploads/2021/08/PolyPeptide_1HY_report_20210817.pdf

PolyPeptide half-year report 2021 1 Content Overview 3 Editorial Key figures Profile Business review 10 Performance Progress Outlook Financial report 14 Interim consolidated income statement Interim consolidated statement of comprehensive income Interim consolidated statement of financial position I...

Read more

https://group.polypeptide.com/app/uploads/2021/08/PolyPeptide_1HY_media-release_20210817_E.pdf

Media Release – ad hoc announcement pursuant to Art. 53 LR PolyPeptide reports strong H1 2021 revenue growth and operating leverage amidst favorable market environment and encouraging business trends Zug, 17 August 2021 – PolyPeptide Group AG (SIX: PPGN), a global leader in peptide custom develo...

Read more

Microsoft Word - PPL_IASB FS 2019 (FINAL).docx

Microsoft Word - PPL_IASB FS 2019 (FINAL).docx POLYPEPTIDE LABORATORIES HOLDING B.V. Consolidated Financial Statements 2019 CONTENTS Consolidated Income Statement 2 Consolidated Statement of Comprehensive Income 3 Consolidated Statement of Financial Position 4 Consolidated Statement of Changes in Eq...

Read more

https://group.polypeptide.com/app/uploads/2021/04/Code-of-business-conduct-and-ethics_PolyPeptideGroup.pdf

Policy and Procedure 2021-04-27 Code of business conduct and ethics Background Quality in every aspect of our business is the hallmark on which the Company was built. Quality at the PolyPeptide Group goes beyond ensuring the quality of our products and maintaining strict adherence to cGMP guidelines...

Read more

https://group.polypeptide.com/app/uploads/2021/08/PPG-time-series.xlsx

Sheet1 PolyPeptide time series selected performance indicators kEUR H1 2018 H2 2018 H1 2019 H2 2019 H1 2020 H2 2020 H1 2021 Revenue 81626 97948 90729 111884 87808 135225 135136 Custom Projects 23280 41379 30550 53738 33504 68368 76207 Contract Manufacturing 48926 49118 51259 48246 42901 57207 45765 ...

Read more

Corporate News – PolyPeptide

Corporate News – PolyPeptide COVID-19 Outbreak Information – Click here for the latest updates Services GMP Compliance Pre-GMP development Production Quality Assurance Quality control Regulatory Support Generic peptides Commercial Manufacturing Commercial Products at PolyPeptide Late Stage Devel...

Read more

Corporate News – PolyPeptide

Corporate News – PolyPeptide COVID-19 Outbreak Information – Click here for the latest updates Services GMP Compliance Pre-GMP development Production Quality Assurance Quality control Regulatory Support Generic peptides Commercial Manufacturing Commercial Products at PolyPeptide Late Stage Devel...

Read more